SCHERBAKOV EUGENE A sold $132K of IPGP

SCHERBAKOV EUGENE A sold 1,524 shares of IPG PHOTONICS CORP (IPGP) at an average of $86.61 ($85.72–$88.68, $0.13M total) across 4 trades on 2026-07-31 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · SCHERBAKOV EUGENE A
Published Aug 4, 2026, 8:56 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 4, 2026, 9:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$IPGP
Neutral
medium confidence
Mentioned
$IPGP
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IPGPNeutralLow
01

Why it matters

The newest information is the specific open-market sale details (shares, price range, total value) and confirmation that it was executed under a pre-arranged Rule 10b5-1 plan.

02

Market read

This provides a fresh insider-selling datapoint for IPGP, but the 10b5-1 structure limits interpretive value for near-term fundamentals.

03

What to watch

Traders should check whether there are multiple consecutive insider sales, changes in total insider ownership, or concurrent company-specific catalysts (earnings, guidance, contracts) that could make the timing more meaningful.

Relevance 3/10Novelty 3/10Timing: filed 2026-08-04 after-hours; reflects trades dated 2026-07-31

Background

The article is an SEC Form 4 insider transaction disclosure for IPG Photonics, reported by a director and 10% owner.

Company-level read

Ticker impact

$IPGPNeutralMedium confidence
Context

IPG Photonics disclosed a director and 10% owner open-market sale of 1,524 shares on 2026-07-31 under a 10b5-1 plan.

Expected impact

Low near-term impact; any move is likely sentiment-driven and should fade unless follow-on selling or other news appears.

Evidence & confidence

The filing is a Form 4 insider transaction with a stated pre-arranged 10b5-1 plan, which typically reduces interpretive signal versus discretionary selling. The disclosed size ($131,993.64) is modest relative to a large-cap’s typical trading flow.

Market effects

No clear sector read-through; this is company-specific insider activity.

None.

None.

Counterpoint

Because the sale is under a 10b5-1 plan, it may be routine liquidity management rather than a bearish signal.

Key entities

  • IPG PHOTONICS CORP

    US-listed company whose insider transaction was disclosed on Form 4.

  • SCHERBAKOV EUGENE A

    Director and 10% owner who sold 1,524 shares across four trades on 2026-07-31 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$IPGPMed

Why IPG Photonics (IPGP) shares are falling today

IPG Photonics (IPGP) shares fell 9.8% after Democratic senators called for slowing AI data center development, impacting chipmakers. Micron paused a $4.5B plant in Taiwan due to labor disputes. IPGP is down 15.9% YTD, trading 59.2% below its 52-week high. Rising Treasury yields also weigh on semiconductor stocks.

$IPGPMed

IPG Photonics Corp (IPGP) (Q3 2026) Earnings Call Highlights: Fourth Straight Quarter

IPG Photonics (IPGP) expects Q4 revenue of $265-$295M, with adjusted gross margin declining to 37-40% due to lower tariff refunds. European sales fell 1% YoY, while defense revenue is lumpy. CEO Dr. Mark Gitin sees long-term growth in battery, semiconductor, and medical sectors. CFO Timothy Mammen notes cost pressures but expects gross margin improvements in 2027. Medical and semiconductor are key growth drivers.

$IPGPLow

IPG Photonics (IPGP) Beat Q3 Estimates, Is It Still Below Fair Value?

IPG Photonics (IPGP) reported Q3 2026 sales of $287.5M and net income of $20.27M, beating estimates. Despite this, shares fell 11.46% in 30 days and 11.40% over 1 year. The stock closed at $74.42, with some analysts valuing it 40% below fair value at $124.14, citing growth opportunities. However, its P/E ratio of 114.9x raises valuation concerns compared to industry peers.

MedAI 8/10

IPG Photonics Corporation Q3 2026 Earnings Call Summary

IPG Photonics reported Q3 2026 revenue growth of 15%, driven by industrial and advanced solutions. Advanced Solutions revenue surged 33% YoY, led by semiconductor and defense applications. The company expects medical business growth to double in 2-3 years post-Lumibird Medical acquisition. Q4 guidance accounts for moderation in China's battery capacity additions. The company maintains a strong balance sheet with $926M in cash and no debt.

$IPGPMedAI 8/10

IPG Photonics (IPGP) Q3 2026 Earnings Call Transcript

IPG Photonics (IPGP) reported Q3 2026 earnings, with revenue up 15% YoY to $288M. Industrial Solutions revenue grew 12% YoY, driven by welding and additive manufacturing. Advanced Solutions revenue increased 33% YoY, with strong growth in semiconductor and defense applications. The company announced the acquisition of Lumibird Medical, expected to close in Q4, expanding its medical laser platform. IPGP plans to host an Investor Day on March 2, 2027.